» Articles » PMID: 37978846

Reconstruction of the Regulatory Hypermethylation Network Controlling Hepatocellular Carcinoma Development During Hepatitis C Viral Infection

Abstract

Hepatocellular carcinoma (HCC) has been associated with hepatitis C viral (HCV) infection as a potential risk factor. Nonetheless, the precise genetic regulatory mechanisms triggered by the virus, leading to virus-induced hepatocarcinogenesis, remain unclear. We hypothesized that HCV proteins might modulate the activity of aberrantly methylated HCC genes through regulatory pathways. Virus-host regulatory pathways, interactions between proteins, gene expression, transport, and stability regulation, were reconstructed using the ANDSystem. Gene expression regulation was statistically significant. Gene network analysis identified four out of 70 HCC marker genes whose expression regulation by viral proteins may be associated with HCC: , , , and . It suggested the following viral protein effects in HCV/human protein heterocomplexes: HCV NS3(p70) protein activates human STAT3 and NOTC1; NS2-3(p23), NS5B(p68), NS1(E2), and core(p21) activate SETD2; NS5A inhibits SMYD3; and NS3 inhibits CCN2. Interestingly, NS3 and E1(gp32) activate c-Jun when it positively regulates and inhibit it when it represses . The discovered regulatory mechanisms might be key areas of focus for creating medications and preventative therapies to decrease the likelihood of HCC development during HCV infection.

Citing Articles

BGRS: bioinformatics of genome regulation and data integration.

Orlov Y, Chen M, Kolchanov N, Hofestadt R J Integr Bioinform. 2023; 20(3).

PMID: 37972410 PMC: 10757072. DOI: 10.1515/jib-2023-0032.

References
1.
Ivanisenko V, Saik O, Ivanisenko N, Tiys E, Ivanisenko T, Demenkov P . ANDSystem: an Associative Network Discovery System for automated literature mining in the field of biology. BMC Syst Biol. 2015; 9 Suppl 2:S2. PMC: 4407185. DOI: 10.1186/1752-0509-9-S2-S2. View

2.
Chung S, Oliva B, Dwabe S, Vadgama J . Combination treatment with flavonoid morin and telomerase inhibitor MST‑312 reduces cancer stem cell traits by targeting STAT3 and telomerase. Int J Oncol. 2016; 49(2):487-98. PMC: 4922839. DOI: 10.3892/ijo.2016.3546. View

3.
Donati B, Ciarrocchi A . Telomerase and Telomeres Biology in Thyroid Cancer. Int J Mol Sci. 2019; 20(12). PMC: 6627113. DOI: 10.3390/ijms20122887. View

4.
Zhen L, Ning G, Wu L, Zheng Y, Yang F, Chen T . Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma. Biosci Rep. 2020; 40(10). PMC: 7536330. DOI: 10.1042/BSR20192593. View

5.
Wang J, Zhou L, Li Z, Zhang T, Liu W, Liu Z . YY1 suppresses FEN1 over-expression and drug resistance in breast cancer. BMC Cancer. 2015; 15:50. PMC: 4348373. DOI: 10.1186/s12885-015-1043-1. View